Error: Could not add to watchlist. X

Vertex Pharmaceuticals Inc

+ Watchlist
VRTX:US
NASDAQ GS
124.47
USD
0.33
0.27%
As of 09:43:45 ET on 06/03/2015.
Open
124.38
Day Range
124.13 - 124.95
Volume
51,101
Previous Close
124.80
52Wk Range
63.68 - 137.50
1 Yr Return
70.45%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-2.69
Market Cap (b USD)
30.420
Shares Outstanding (m)
243.752
Price/Sales (TTM)
49.00
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company develops drugs for the treatment of cystic fibrosis, autoimmune diseases, cancer, inflammatory bowel disease, and neurological disorders.
ADDRESS
50 Northern Avenue
Boston, MA 02210
United States
PHONE
1-617-341-6100
  • Jeffrey M Leiden "Jeff"
    President/CEO
  • Ian F Smith
    Exec VP/CFO
  • Stuart A Arbuckle
    Exec VP/Chief Commercial Ofcr
  • David Altshuler
    Exec VP:Global Research
  • Jeffrey A Chodakewitz "Jeff"
    Exec VP:Global Medicines Dev
Show More